TANABE PHARMA AMERICA, INC. – Trademark Portfolio
Entity Type: 03
TANABE PHARMA AMERICA, INC. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 2 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include REFINE-ALS, ALS PATHWAYS, and EMBRACE YOUR NOW. The owner is based in JERSEY CITY, NJ.
525 WASHINGTON BOULEVARD, SUITE 1100
JERSEY CITY, NJ 07310
Showing of trademarks Trademarks
Trademark Classifications
TANABE PHARMA AMERICA, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does TANABE PHARMA AMERICA, INC. have?
TANABE PHARMA AMERICA, INC. has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does TANABE PHARMA AMERICA, INC. file in?
TANABE PHARMA AMERICA, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 42 (Computer & Scientific). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are TANABE PHARMA AMERICA, INC.'s most well-known trademarks?
TANABE PHARMA AMERICA, INC.'s registered trademark portfolio includes well-known marks such as REFINE-ALS, ALS PATHWAYS, and EMBRACE YOUR NOW. These are among 3 currently registered trademarks in the portfolio.
What is TANABE PHARMA AMERICA, INC.'s trademark registration success rate?
TANABE PHARMA AMERICA, INC. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.